Medicare Enrolled

Dr. Leana Oppenheim, D.O

Neurology · St Petersburg, FL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
1201 5TH AVE N STE 202, St Petersburg, FL 33705
7278207701
Registered in NPPES since 2013
NPI: 1326487174 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Oppenheim from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Oppenheim? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Oppenheim

Dr. Leana Oppenheim is a neurology specialist in St Petersburg, FL, with 13 years of NPI registration. Based on federal Medicare data, Dr. Oppenheim performed 475 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Oppenheim received a total of $29,985 from 67 pharmaceutical and/or device companies across 400 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Oppenheim is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 13 years of NPI registration ▲ 475 Medicare services $29,985 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
475
Medicare services
Bottom 48% in FL for neurology
Not available
Unique patients (not deduplicated)
$104
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
239 $91 $310
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
70 $94 $257
New patient office visit, complex (60-74 min) 47 $130 $496
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
45 $123 $408
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
40 $119 $389
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
34 $137 $498
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$29,985
Total received (2018-2024)
Avg $4,284/year across 7 years
Top 12% in FL for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
67
Companies
400
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$14,988
2023
$11,944
2022
$767
2021
$518
2020
$216
2019
$1,099
2018
$452

Payments by company (2024)

ABBVIE INC.
$12,241
MITSUBISHI TANABE PHARMA AMERICA, INC.
$253
Novartis Pharmaceuticals Corporation
$207
Neurocrine Biosciences, Inc.
$200
Biogen, Inc.
$179
PFIZER INC.
$165
Teva Pharmaceuticals USA, Inc.
$159
Alexion Pharmaceuticals, Inc.
$156
Takeda Pharmaceuticals U.S.A., Inc.
$139
Lundbeck LLC
$133
UCB, Inc.
$117
Eisai Inc.
$101
CATALYST PHARMACEUTICALS, INC.
$96
Lilly USA, LLC
$86
GE HEALTHCARE
$81
Sumitomo Pharma America, Inc.
$69
Neurelis, Inc.
$62
Acorda Therapeutics, Inc
$55
ACADIA Pharmaceuticals Inc
$49
Amgen Inc.
$48
Merz Pharmaceuticals, LLC
$47
Vanda Pharmaceuticals Inc.
$46
Genentech USA, Inc.
$40
Celgene Corporation
$38
ARGENX US, INC.
$35
Sarepta Therapeutics, Inc.
$29
Alnylam Pharmaceuticals Inc.
$29
Janssen Pharmaceuticals, Inc
$24
Grifols USA, LLC
$24
TG Therapeutics, Inc.
$23
Microtransponder, Inc.
$23
AstraZeneca Pharmaceuticals LP
$19
Nevro Corp.
$16
Top 3 companies account for 84.7% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$22,259
Biogen, Inc.
$488
Teva Pharmaceuticals USA, Inc.
$469
Novartis Pharmaceuticals Corporation
$433
PFIZER INC.
$356
Allergan Inc.
$342
Alexion Pharmaceuticals, Inc.
$341
UCB, Inc.
$321
GE HealthCare
$304
Neurocrine Biosciences, Inc.
$297
Takeda Pharmaceuticals U.S.A., Inc.
$256
Sunovion Pharmaceuticals Inc.
$254
MITSUBISHI TANABE PHARMA AMERICA, INC.
$253
ARGENX US, INC.
$228
Lilly USA, LLC
$224
Acorda Therapeutics, Inc
$215
Allergan, Inc.
$187
Eisai Inc.
$165
Biohaven Pharmaceuticals, Inc.
$163
Medtronic, Inc.
$159
Lundbeck LLC
$133
CATALYST PHARMACEUTICALS, INC.
$124
Horizon Therapeutics plc
$120
Sumitomo Pharma America, Inc.
$106
CSL Behring
$106
Ortho Dermatologics, a division of Bausch Health US, LLC
$99
Supernus Pharmaceuticals, Inc.
$95
GE HEALTHCARE
$81
Amgen Inc.
$78
BANNER LIFE SCIENCES, LLC
$72
SK Life Science, Inc.
$65
Genentech USA, Inc.
$65
PORTOLA PHARMACEUTICALS, INC.
$62
Neurelis, Inc.
$62
Grifols USA, LLC
$58
Celgene Corporation
$51
Otsuka America Pharmaceutical, Inc.
$50
ACADIA Pharmaceuticals Inc
$49
Biohaven Pharmaceutical Holding Company Ltd.
$49
Harmony Biosciences LLC
$49
JAZZ PHARMACEUTICALS INC.
$48
Merz Pharmaceuticals, LLC
$47
Vanda Pharmaceuticals Inc.
$46
Upsher-Smith Laboratories LLC
$43
AbbVie Inc.
$41
Janssen Pharmaceuticals, Inc
$41
Sarepta Therapeutics, Inc.
$29
Nevro Corp.
$29
Alnylam Pharmaceuticals Inc.
$29
Avanir Pharmaceuticals, Inc.
$27
UPSHER-SMITH LABORATORIES LLC
$26
Jazz Pharmaceuticals Inc.
$25
NOVARTIS PHARMACEUTICALS CORPORATION
$24
TG Therapeutics, Inc.
$23
Microtransponder, Inc.
$23
IMPEL PHARMACEUTICALS INC.
$22
AbbVie, Inc.
$20
Xeris Pharmaceuticals, Inc.
$20
AstraZeneca Pharmaceuticals LP
$19
Corium, LLC
$19
IDORSIA PHARMACEUTICALS US INC
$16
Zyla Life Sciences
$15
EMD Serono, Inc.
$15
Amneal Pharmaceuticals LLC
$14
Zyla Life Sciences, Inc.
$14
Medtronic USA, Inc.
$12
Egalet US Inc
$11
Top 3 companies account for 77.4% of all-time payments
Associated products mentioned in payments ›
ADUHELM · AFINITOR · AGAMREE · AJOVY · AMYVID · ANDEXXA · APTIOM · AUSTEDO · Adlarity · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BRIUMVI · COMIRNATY · Duopa · EMGALITY · EPIDIOLEX · Evrysdi · FIRDAPSE · Fintepla · GAMMAGARD · GILENYA · GVOKE PFS · Gamunex-C · HYQVIA · Hizentra · INBRIJA · INGREZZA · INTELLIS ADAPTIVESTIM · KESIMPTA · KISUNLA · Leqembi · MAYZENT · Mavenclad · NUEDEXTA · NUPLAZID · NURTEC ODT · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONPATTRO · Ocrevus · Ongentys · PLEGRIDY · PONVORY · Ponvory · QULIPTA · QUVIVIQ · RADICAVA · REXULTI · RYTARY · Rystiggo · SILIQ · SOLIRIS · SPINRAZA · SPRIX · SYNCHROMED · Senza · TOPIRAMATE Extended Release Capsules · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · Wakix · XARELTO · XCOPRI · XYREM · XYWAV · Xeomin · ZEMBRACE SYMTOUCH · ZEPOSIA · Zilbrysq
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a neurology specialist in St Petersburg?
Compare neurologists in the St Petersburg area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists in nearby ZIP areas
161
County median income
$70,293
Nearest hospital to ZIP centroid (approximate)
ST ANTHONYS HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Oppenheim is a clinical cardiology specialist, with moderate Medicare volume.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Oppenheim experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Oppenheim performed 239 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Oppenheim receive payments from pharmaceutical companies?
Yes. Dr. Oppenheim received a total of $29,985 from 67 companies across 400 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Oppenheim's costs compare to other neurologists in St Petersburg?
Dr. Oppenheim's average Medicare payment per service is $104. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Oppenheim) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →